Back to results
US 12,576,128 B2Granted
Genetically engineered microorganisms and methods of use
AssigneeUniversity of Massachusetts
InventorsVanni Bucci, Benedikt Mortzfeld, Jacob Palmer
Life of this patent
Estimating the term…
Abstract
This disclosure relates to genetically engineered microorganisms for treating or reducing the risk of bacterial infections or dysbiosis, and further discloses methods of making and using such microorganisms.
Claims20
A genetically engineered microorganism capable of producing functional microcin 147 that can inhibit the growth of bacteria, wherein the microorganism comprises
- a first microcin operon,
- a first controllable promoter for the first microcin operon,
- a second microcin operon, and
- a second controllable promoter for the second microcin operon;
- wherein the first microcin operon comprises microcin genes mciI, mciA, mchC, mchD, mchE, and mchF, but not mchS1 or mchS4,
- wherein the first controllable promoter controls a level of expression of at least one of the microcin genes, thereby controlling an amount of microcin produced by the genetically engineered microorganism,
- wherein the second microcin operon comprises microcin gene mchA, and wherein the second controllable promoter controls a level of expression of the mchA gene, thereby controlling an amount of microcin produced by the genetically engineered microorganism,
- wherein either or both of the first microcin operon and the first controllable promoter are heterologous to the microorganism, and
- wherein the functional microcin I47 inhibits one or more of Klebsiella, Salmonella, Shigella, and Escherichia.
6 more elements
Dependencies are inferred from the claim text.